recombinant factor Xa inhibitor peptide (Peking University Health Science Center)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namerecombinant factor Xa inhibitor peptide (Peking University Health Science Center)
Drug Alias Nameantithrombotic peptide (Peking University Health Science Center)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesPeking University Health Science Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPeking University Health Science Center
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A